Skip to content

Influence of oxidative components on a vascular function improvement effect of polyphenol.

Influence of oxidative components on a vascular function improvement effect of polyphenol. - Influence of oxidative components on a vascular function improvement effect of polyphenol.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000025355
Enrollment
10
Registered
2016-12-21
Start date
2016-11-07
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

A drink: The polyphenol drink containing an oxidization component. B drink: The polyphenol drink which reduced the oxidization component by X treatment. C drink: The polyphenol drink which reduced t

Sponsors

Kao Coporation
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1) Subjects whose fasting blood glucose levels are ranged to less than 126mg/dL 2) Subjects whose HbA1c1 levels are ranged to less than 6.2% 3) Subjects whose BMI are from 18.5 Kg/m2 to less than 35 Kg/m2 4) Subjects who can make self-judgment and are voluntarily giving written informed consent

Exclusion criteria

Exclusion criteria: 1) Subjects who take continuous medical treatment 2) Subjects who are contracting heart disease, liver disease, kidney disease, digestive disease and allergy disease 3) Subjects with smoking habit 4) Subjects who are not eligible due to physician's judgment

Design outcomes

Primary

MeasureTime frame
Blood samples were collected before ingestion and at 0.5,1 and 2 hours after ingestion. FMD was measured before and 1, 2 and 4 hours after ingestion. Urine samples were collected before ingestion and accumulation urine samples were pooled during the postprandial periods for 2 and 4 hrs. Primary outcomes are oxidative stress markers and vascular endothelial function.

Secondary

MeasureTime frame
Key secondary outcomes are blood glucose.

Countries

Japan

Contacts

Public ContactHiroko Jokura

Kao Coporation R&B-Core Technology-Biological Science Research

joukura.hiroko@kao.co.jp0285-68-7164

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026